Institution statistics - MEDICINE, HEALTH

QUEEN MARY AND WESTFIELD COLLEGE, UNIVERSITY OF LONDON - United Kingdom 

Ranking results:

Past rankings:
Subject specific rankings are not yet available..
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 MEDICINE, HEALTH):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 40
As coordinator: 3
As participant: 37
Sole participant: 0
Coordinator / Participant Ratio: 0.08*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2013 0 2.431.035 2.431.035 1
2011 0 60.506.819 1.788.485 5
2010 0 4.467.062 349.026 2
2009 993.852 8.807.926 447.357 1 2
2008 0 5.982.457 581.405 2
2006 0 32.100.219 1.779.305 6
2005 0 24.555.154 1.335.039 5
2004 1.699.228 49.113.869 1.928.011 1 7
2003 0 999.528 33.318 1
2002 0 5.895.063 611.578 4
2001 524.709 2.232.014 383.801 1 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE47
UNIVERSITY COLLEGE LONDON26
CONSIGLIO NAZIONALE DELLE RICERCHE22
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V22
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE22
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE21
COMMISSARIAT A L'ENERGIE ATOMIQUE19
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE19
KAROLINSKA INSTITUTE19
KING'S COLLEGE LONDON19
KATHOLIEKE UNIVERSITEIT LEUVEN17
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE16
UNIVERSITE DE GENEVE14
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN13
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD13
UNIVERSITY OF HELSINKI13
UPPSALA UNIVERSITET13
INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET EN AUTOMATIQUE12
THE UNIVERSITY OF EDINBURGH12
THE UNIVERSITY OF MANCHESTER12
UNIVERSITE CATHOLIQUE DE LOUVAIN12
TECHNISCHE UNIVERSITAET DRESDEN11
UNIVERSITA DEGLI STUDI DI PADOVA11
UNIVERSITY OF GLASGOW11
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS10
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS10
JOZEF STEFAN INSTITUTE10
RIJKSUNIVERSITEIT GRONINGEN10
THE UNIVERSITY OF SHEFFIELD10
UNIVERSITY OF BIRMINGHAM10
CHARITE UNIVERSITAETSMEDIZIN BERLIN9
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH9
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS9
INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS9
INTERUNIVERSITAIR MICRO ELECTRONICA CENTRUM VZW9
LUNDS UNIVERSITET9
TECHNISCHE UNIVERSITAET MUENCHEN9
TECHNISCHE UNIVERSITEIT EINDHOVEN9
UMEA UNIVERSITET9
UNIVERSITAT POMPEU FABRA9
UNIVERSITE LOUIS PASTEUR STRASBOURG 19
UNIVERSITY OF COPENHAGEN9
UNIVERSITY OF LEEDS9
UNIVERSITY OF SOUTHAMPTON9
ACADEMISCH ZIEKENHUIS GRONINGEN8
CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS8
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM8
LINKOEPING UNIVERSITY8
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS8
THALES8
THE PROVOST FELLOWS FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN8
THE UNIVERSITY OF NOTTINGHAM8
UNIVERSITE LIBRE DE BRUXELLES8
UNIVERSITEIT GENT8
UNIVERSITY OF NEWCASTLE UPON TYNE8
UNIVERSITY OF OSLO8
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS7
CHALMERS TEKNISKA HOEGSKOLA AB7
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER7
DUBLIN CITY UNIVERSITY7
FUNDACION TECNALIA RESEARCH & INNOVATION7
INSTITUT PASTEUR7
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV7
REGION HOVEDSTADEN7
TECHNISCHE UNIVERSITEIT DELFT7
THE UNIVERSITY OF WARWICK7
UNIVERSIDAD AUTONOMA DE MADRID7
UNIVERSIDAD DE ZARAGOZA7
UNIVERSITA DEGLI STUDI DI PISA7
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA7
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA7
UNIVERSITAET ZUERICH7
UNIVERSITAT AUTONOMA DE BARCELONA7
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI7
UNIVERSITEIT VAN AMSTERDAM7
UNIVERSITY OF BOLOGNA7
UNIVERSITY OF CRETE7
UNIVERSITY OF WALES CARDIFF7
VTT TECHNICAL RESEARCH CENTRE OF FINLAND7
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER7
AIRBUS FRANCE SAS6
ALBERT LUDWIGS UNIVERSITAET FREIBURG6
BRUNEL UNIVERSITY6
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL6
CONSORZIO NAZIONALE INTERUNIVERSITARIO PER LE TELECOMUNICAZIONI6
DANMARKS TEKNISKE UNIVERSITET6
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT6
ISTITUTO NAZIONALE DI FISICA NUCLEARE6
PANEPISTIMIO IOANNINON6
SERVICIO MADRILENO DE SALUD6
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE6
THE UNIVERSITY OF LIVERPOOL6
UNIVERSIDADE DO MINHO6
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II6
UNIVERSITA DEGLI STUDI DI PERUGIA6
UNIVERSITA DEGLI STUDI DI TRENTO6
UNIVERSITA DEGLI STUDI DI VERONA6
UNIVERSITAET BASEL6
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK6
UNIVERSITY OF AARHUS6
Constancy:

Total number of partners:4188

Partner loyalty:
Frequent Partner: (> 2 projects): 1852
Rare Partner: 2336

Frequent / Rare Partner Ratio: 0.79

Diversity:

Categories:
Category:No:
RTD HORIZONTAL TOPICS139
SOCIAL AND ECONOMIC CONCERNS106
BIOLOGICAL SCIENCES91
INDUSTRY AND TECHNOLOGY74
PROTECTING MAN AND HIS ENVIRON20
ENERGY3
MEASUREMENTS AND STANDARDS2
AGRICULTURE AND MARINE RESOURC2
PHYSICAL AND EXACT SCIENCES1

Project overview:

Start dateProjectacronymrolefundingpartners
2013-06-01Building a Human Tumour Microenvironment CANBUILDparticipant2.431.0351
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2011-06-13Multifunctional Nanotechnology for selective detection and Treatment of cancer MULTIFUNparticipant9.799.99417
2011-03-01EUROmediCAT: Safety of Medication use in Pregnancy in Relation to Risk of Congenital Malformations EUROMEDICATparticipant2.996.1009
2011-02-01More Medicines for Tuberculosis MM4TBparticipant11.873.05225
2011-01-01Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics PREDICTparticipant5.841.00914
2010-12-01Easy and rapid generation of light-emitting somatic-transgenic mice to monitor specific disease states and to screen effective drugs SomaBioparticipant1.471.2723
2010-05-01Accessing Medicines in Africa and South Asia AMASAparticipant2.995.7908
2009-09-01Molecular targets open for regulation by the gut flora new avenues for improved diet to optimize European health TORNADOparticipant5.895.60123
2009-09-01European network on noise and health ENNAHcoordinator993.85234
2009-01-01Improvement in postoperative pain outcome PAIN-OUTparticipant2.912.32518
2008-06-01IBD: proteases offer new targets for drug discovery IPODDparticipant2.999.25012
2008-01-01A new platform for fast molecular detection of MDR and XDR resistant strains of M. tuberculosis and of drug resistant malaria TM-RESTparticipant2.983.2079
2006-10-01Evaluation and control of neglected Mucosal Enteric infections in childhood CONTENTparticipant2.500.00012
2006-10-01CD40 ligand-based modalities for the treatment of solid tumours APOTHERAPYparticipant1.895.9008
2006-09-01Intelligent multi-reactive textiles integrating nano-filler based CPC-fibres INTELTEXparticipant4.699.72824
2006-08-01Novel molecular diagnostic tools for the prevention and diagnosis of pancreatic cancer MOLDIAG-PACAparticipant8.434.59121
2006-01-01Neutralizing antibodies on Interferon beta in Multiple Sclerosis NABINMSparticipant3.500.00015
2006-01-01New medicines for tuberculosis NM4TBparticipant11.070.00022
2005-11-01Innovative chemokine-based therapeutic strategies for autoimmunity and chronic inflammation INNOCHEMparticipant11.889.09629
2005-07-01Rare genetic skin disease: advancing diagnosis, management and awareness through a European network GENESKINparticipant1.238.19929
2005-07-01Ex vivo gene therapy for recessive dystrophic epidermlysis bullosa: pre-clinical and clinical studies THERAPEUSKINparticipant284.0009
2005-01-01Biosensors based on membrane organisation to replace animal testing BBMOparticipant443.87816
2005-01-01Eicosanoids and Nitric Oxide: Mediators of Cardiovascular, Cerebral & Neoplastic Diseases EICOSANOXparticipant10.699.98113
2004-10-01Developing Molecular Medicines for Cancer in the Post-Genome Era MOL CANCER MEDparticipant3.880.00015
2004-10-01Psychobiology of posttraumatic stress disorder PBPTSDparticipant1.296.8699
2004-08-01Components, organisation, costs and outcomes of health care and community based interventions for people with posttraumatic stress following war and conflict in the Balkans CONNECTcoordinator1.699.2288
2004-05-01European Vigilance Network for the Management of Antiviral Drug Resistance VIRGILparticipant9.000.00058
2004-01-01Targeting cell migration in chronmic inflammation MAINparticipant10.000.00021
2004-01-01Adult mesenchymal stem cells engineering for connective tissue disorders. From the bench to the bed side GENOSTEMparticipant8.752.00024
2004-01-01Extracellular Proteases and the Cances Degradome: Innovative Diagnostic Markers, Therapeutic Targets and Tumour Imaging Agents CANCERDEGRADOMEparticipant10.185.00036
2004-01-01Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe EUROPEAN LEUKEMIANETparticipant6.000.000177
2003-01-01Policy interpretation network on children's health and environment PINCHEparticipant999.52830
2002-10-01European evaluation of coercion in psychiatry and harmonisation of best clinical practise (EUNOMIA) EUNOMIAparticipant1.697.09211
2002-09-01Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as drugs against tuberculosis (NEW ANTIMYCOBACTERIALS) NEW ANTIMYCOBACTERIAparticipant1.500.0008
2002-09-01Epidemiology of human papillomavirus (hpv) infection, ultraviolet (uv) radiation in relation to non-melanoma skin cancer EPI-HPV-UV-CAparticipant1.199.94310
2002-09-01Analysis of the molecular mechanisms of hepatitis C virus (HCV) resistance to antiviral therapy HEPAC-RESISTparticipant1.498.02810
2001-12-01Enterovirus infections as a risk factor for type 1 diabetes VIRUSES IN DIABETESparticipant1.298.6867
2001-12-01Robust chemical sensors and biosensors for rapid on-line identification of freshly collected and processed milk ROSEPROMILKparticipant933.32810
2001-03-01The role of home respiratory ventilators in the management of chronic respiratory failure coordinator524.7095

Alias institution names:
  • QUEEN MARY UNIVERSITY OF LONDON

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum